Arrowstreet Capital, Limited Partnership Seagen Inc. Transaction History

Arrowstreet Capital, Limited Partnership

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $11.5 Million - $13.7 Million	-84,974 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $8.56 Million - $11.9 Million	62,274 Added 274.33%	84,974 $11.8 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $3.74 Million - $4.81 Million	22,700 New	22,700 $3.98 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.